AI System Predicts Alzheimer’s with 93% Accuracy Using Brain Scans

Health & LifestyleNews
233

Listen to article (english)

Translate to Spanish or other 102 languages!

Alzheimer’s disease is a progressive condition that can cause memory loss and cognitive decline. Detecting Alzheimer’s typically requires a comprehensive medical evaluation, which a person may only receive after presenting symptoms that could suggest a decline in brain functioning. Image for illustration purposes
Alzheimer’s disease is a progressive condition that can cause memory loss and cognitive decline. Detecting Alzheimer’s typically requires a comprehensive medical evaluation, which a person may only receive after presenting symptoms that could suggest a decline in brain functioning. Image for illustration purposes

Mega Doctor News

- Advertisement -

Medical News Today

Alzheimer’s disease is a progressive condition that can cause memory loss and cognitive decline. Detecting Alzheimer’s typically requires a comprehensive medical evaluation, which a person may only receive after presenting symptoms that could suggest a decline in brain functioning.

Alzheimer’s disease slowly worsens over time, and an early, accurate diagnosis can be beneficial for treating the progression of the disease. However, early diagnosis is often challenging because initial symptoms may resemble typical age-related changes in memory or thinking

- Advertisement -

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/ai-tool-predicts-alzheimers-using-brain-scans

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
STHS Edinburg Welcomes St. Patrick’s Day Baby
Next article
Why Taking a Walk After Eating Can Boost Your Digestion

More Articles

STHS Dedicating Latest “South Texas Healthy Living” Episode to Arthritis Education, July 26th

More than 58 million U.S. adults are living with doctor-diagnosed arthritis, according to the Centers for Disease Control and Prevention (CDC), making it the nation’s leading cause of disability.

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.

Physicians Warn of Rising ER Visits Linked to E-Bikes and Scooters

Mega Doctor News CLEVELAND CLINIC - As electric bikes and scooters grow in...

STHS Heart Ranks Among Nation’s Top Hospitals for Heart Attack Care

Every year, more than 800,000 people in the United States suffer a heart attack, according to the Centers for Disease Control and Prevention, an event that occurs approximately every 40 seconds.
- Advertisement -